Recently, results from Volcano Corporation's (VOLC) PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study were published in The New England Journal of ...

Volcano Corporation (Nasdaq: VOLC), a provider of intravascular ultrasound (IVUS) and functional measurement (FM) products designed to enhance the diagnosis and treatment of vascular and structural ...

SAN DIEGO, CHRON Volcano Corporation today announced its participation in the Paris course for Revascularization (EuroPCR) from May 17 — 20. Volcano's focus will be on highlighting the strength of its ...

Release of these novel precision guidance tools will be demonstrated in live cases, symposia and training programs throughout the week SAN DIEGO, CA -- Volcano Corporation, a leading company focused ...

SAN DIEGO, CA, and BARCELONA, SPAIN, 19 May 2009 – Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis of coronary and peripheral ...

Volcano Corp. has announced it has received FDA clearance for its new intravascular ultrasound catheter, according to a news release. The Visions PV .035 digital IVUS catheter is designed to image ...

SAN DIEGO, Sept. 21 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular therapy guidance ...

Please provide your email address to receive an email when new articles are posted on . At 3 years, among the 1,423 patients for whom data were available, TVF, defined as cardiac death, target vessel ...

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This ...

Volcano Corporation VOLC, a leading developer and manufacturer of precision guided tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced ...